Antonio is a Swedish molecular biologist and entrepreneur from California. He is a cofounder of MicroSynbiotiX, a venture-backed algal synthetic biology company that is developing plant-based oral vaccines and therapeutics for the aquaculture industry. He obtained his B.Sc. from the University of California, Santa Cruz, and his M.Sc. from the University of Basel in molecular biology. Antonio is currently a recent graduate scientist at Novartis, performing genetic CRISPR screening of 3D organoids to find new potentially druggable targets. He is also starting his PhD in Microbiology and Immunology at the University of Zurich.